Data as of 1:06pm ET
| +0.47 / +1.88%|
The 8 analysts offering 12-month price forecasts for Hyperion Therapeutics Inc have a median target of 36.00, with a high estimate of 40.00 and a low estimate of 32.00. The median estimate represents a +41.07% increase from the last price of 25.52.
The current consensus among 8 polled investment analysts is to Buy stock in Hyperion Therapeutics Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.